Fig 3. A case of AXL 3+-expressing lung adenocarcinoma that responded well to gefitinib.
(A) Pre-treatment and (B) post-treatment (6 months after initiation of gefitinib, CT scans are shown.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.